Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Furosemide is a loop diuretic and an inhibitor of the Na+/K+/2Cl- (NKCC) cotransporters, NKCC1 and NKCC2 (Kis = ~10 µM for both).1,2 In vivo, furosemide (0.1 mg/kg, p.o.) increases diuresis in beagle dogs.3 Furosemide (30 mg/kg) reduces ventricular collagen deposition and fibrosis in a rat model of dilated cardiomyopathy.4 It is also an inhibitor of carbonic anhydrase I (CAI), CAII, and CAIII (Kis = 0.052-0.065 µM) and organic ion transporter 1 (OAT1; Ki = 9.5 µM), as well as a GABAA receptor antagonist.5,6,7 This product is also available as an analytical reference standard (Item No. 26298).
WARNING This product is not for human or veterinary use.
1. Molecular cloning and functional expression of the K-
2. Physiology and pathophysiology of SLC12A1/2 transporters. Pflugers Arch. 466(1), 91-105 (2014).
3. Comparison between the effects of torsemide and furosemide on the reninangiotensin-
4. Comparative effects of torasemide and furosemide on gap junction proteins and cardiac fibrosis in a rat model of dilated cardiomyopathy. Biofactors 43(2), 187-194 (2017).
5. Carbonic anhydrase inhibitors. Interaction of indapamide and related diuretics with 12 mammalian isozymes and X-
6. The novel process for the preparation of (1R,2R,3aS,9aS)-
7. Dihomogammalinolenic acid, but not eicosapentaenoic acid, activates washed human platelets. Biochim. Biophys. Acta 801(2), 265-276 (1984).